Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Aug 28, 2026

NGEN — NervGen Pharma Corp. Dilution Risk Tracker

Track NGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NGEN — Get alerts when the score changes →

As of August 28, 2026, NervGen Pharma Corp. (NGEN) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. NervGen Pharma Corp. has a market capitalization of $219.84M, 79.65M shares outstanding, 44 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NGEN.
🔔 Track NGEN — Get forecast alerts →

Market Data

Market Cap$219.84M
Shares Outstanding79.65M
Float68.03M
Cash$12.00M
DebtN/A
Short InterestN/A

Institutional Holdings

44 institutional holders · 1.68M shares
#1 PFG Investments, LLC 201.0K shares
#2 BANK OF AMERICA CORP /DE/ 200.7K shares
#3 MARSHALL WACE, LLP 200.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.44M
Days to Cover9.8
% of Float8.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track NGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NGEN
NGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.